Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
14.72
-0.35 (-2.32%)
At close: Apr 25, 2025, 4:00 PM
14.80
+0.08 (0.54%)
Pre-market: Apr 28, 2025, 8:45 AM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.50 billion as of April 28, 2025. Its market cap has decreased by -44.27% in one year.
Market Cap
2.50B
Enterprise Value
2.13B
1-Year Change
-44.27%
Ranking
Category
Stock Price
$14.72
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.50B, an increase of 1,910.33%. That is a compound annual growth rate of 67.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |